CD8A and hepatocellular carcinoma: The study by Gabrielson et al. analyzed the cumulative role of intratumoral CD3+ and CD8+ T cells in combination with programmed death ligand 1 (PD-L1) as prognostic markers for HCC on 65 HCC patients (stage I to IV), who underwent primary tumor resection [4] (Fig. 2).